EMD-20911

Single-particle
4.7 Å
EMD-20911 Deposition: 04/11/2019
Map released: 19/02/2020
Last modified: 25/11/2020
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-20911

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Group 1 H1 influenza stem nanoparticle with a group 2-like N-linked glycosylation site at position 38

EMD-20911

Single-particle
4.7 Å
EMD-20911 Deposition: 04/11/2019
Map released: 19/02/2020
Last modified: 25/11/2020
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus
Sample: H1ssF gN38

Deposition Authors: Tsybovsky Y, Stephens T, Kanekiyo M, Graham BS
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses.
PUBMED: 32034141
DOI: doi:10.1038/s41467-020-14579-4
ISSN: 2041-1723